These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26990976)

  • 1. Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin.
    Xu Q; Chen J; Ni S; Tan C; Xu M; Dong L; Yuan L; Wang Q; Du X
    Mod Pathol; 2016 Jun; 29(6):546-56. PubMed ID: 26990976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated tool for determining the primary origin site of metastatic tumours.
    Santos MTD; Souza BF; Cárcano FM; Vidal RO; Scapulatempo-Neto C; Viana CR; Carvalho AL
    J Clin Pathol; 2018 Jul; 71(7):584-593. PubMed ID: 29248889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiles help identify the tissue of origin for metastatic brain cancers.
    Wu AH; Drees JC; Wang H; VandenBerg SR; Lal A; Henner WD; Pillai R
    Diagn Pathol; 2010 Apr; 5():26. PubMed ID: 20420692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Clinical Validation of a 90-Gene Expression Assay for Identifying Tumor Tissue Origin.
    Ye Q; Wang Q; Qi P; Chen J; Sun Y; Jin S; Ren W; Chen C; Liu M; Xu M; Ji G; Yang J; Nie L; Xu Q; Huang D; Du X; Zhou X
    J Mol Diagn; 2020 Sep; 22(9):1139-1150. PubMed ID: 32610162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.
    Kerr SE; Schnabel CA; Sullivan PS; Zhang Y; Huang VJ; Erlander MG; Brachtel EF; Dry SM
    Mod Pathol; 2014 Jan; 27(1):44-54. PubMed ID: 23846576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.
    Rosenwald S; Gilad S; Benjamin S; Lebanony D; Dromi N; Faerman A; Benjamin H; Tamir R; Ezagouri M; Goren E; Barshack I; Nass D; Tobar A; Feinmesser M; Rosenfeld N; Leizerman I; Ashkenazi K; Spector Y; Chajut A; Aharonov R
    Mod Pathol; 2010 Jun; 23(6):814-23. PubMed ID: 20348879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin.
    Saller JJ; Haider M; Al-Diffalha S; Coppola D
    Anticancer Res; 2022 Mar; 42(3):1381-1396. PubMed ID: 35220231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.
    Handorf CR; Kulkarni A; Grenert JP; Weiss LM; Rogers WM; Kim OS; Monzon FA; Halks-Miller M; Anderson GG; Walker MG; Pillai R; Henner WD
    Am J Surg Pathol; 2013 Jul; 37(7):1067-75. PubMed ID: 23648464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient identification of miRNAs for classification of tumor origin.
    Søkilde R; Vincent M; Møller AK; Hansen A; Høiby PE; Blondal T; Nielsen BS; Daugaard G; Møller S; Litman T
    J Mol Diagn; 2014 Jan; 16(1):106-15. PubMed ID: 24211363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
    Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
    Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate classification of metastatic brain tumors using a novel microRNA-based test.
    Mueller WC; Spector Y; Edmonston TB; St Cyr B; Jaeger D; Lass U; Aharonov R; Rosenwald S; Chajut A
    Oncologist; 2011; 16(2):165-74. PubMed ID: 21273512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.
    van Laar RK; Ma XJ; de Jong D; Wehkamp D; Floore AN; Warmoes MO; Simon I; Wang W; Erlander M; van't Veer LJ; Glas AM
    Int J Cancer; 2009 Sep; 125(6):1390-7. PubMed ID: 19536816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patients.
    Sun W; Wu W; Wang Q; Yao Q; Feng Q; Wang Y; Sun Y; Liu Y; Lai Q; Zhang G; Qi P; Sun Y; Qian C; Ren W; Luo Z; Chen J; Wang H; Xu Q; Zhou X; Sun W; Lin D
    J Transl Med; 2022 Mar; 20(1):114. PubMed ID: 35255924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a gene expression tumour classifier for cancer of unknown primary.
    Tothill RW; Shi F; Paiman L; Bedo J; Kowalczyk A; Mileshkin L; Buela E; Klupacs R; Bowtell D; Byron K
    Pathology; 2015 Jan; 47(1):7-12. PubMed ID: 25485653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings.
    Li M; Li H; Hong G; Tang Z; Liu G; Lin X; Lin M; Qi L; Guo Z
    BMC Cancer; 2019 Jan; 19(1):67. PubMed ID: 30642283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.
    Pillai R; Deeter R; Rigl CT; Nystrom JS; Miller MH; Buturovic L; Henner WD
    J Mol Diagn; 2011 Jan; 13(1):48-56. PubMed ID: 21227394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.